Related Experiment Videos

Hepatitis C: virology, epidemiology, clinical course, and treatment

O Weiland¹, R Schvarcz

¹Dept. of Infectious Diseases, Karolinska Institute, Roslagstull Hospital, Stockholm, Sweden.

Scandinavian Journal of Gastroenterology

|May 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.

European journal of clinical pharmacology·2018

Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C.

Journal of viral hepatitis·2018

Activated Cellular Immunity in Chronic Hepatitis C.

Hematology (Amsterdam, Netherlands)·2016

Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015

Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

Alimentary pharmacology & therapeutics·2015

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.

Journal of viral hepatitis·2013

See all related articles